Bereich
Dermatologie | Venerologie | Allergologie
DERMA · Dept. IV
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
Bilich T, Flatz L, Held S, Brossart P, Märklin M, Wagner P, Erne E, Klein R, Rammensee H, Salih H, Berner F, Wacker M, Roerden M, Maringer Y, Nelde A, Heitmann J, Dubbelaar M, Peter A, Hörber S, Bauer J, Rieth J, Walz J. Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer. Cancer Discov 2021; 11:1982-1995.
19.05.2021Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
19.05.2021Cancer Discov 2021; 11:1982-1995
Bilich Tatjana, Flatz Lukas, Held Stefanie, Brossart Peter, Märklin Melanie, Wagner Philipp, Erne Eva, Klein Reinhild, Rammensee Hans-Georg, Salih Helmut R, Berner Fiamma, Wacker Marcel, Roerden Malte, Maringer Yacine, Nelde Annika, Heitmann Jonas S, Dubbelaar Marissa L, Peter Andreas, Hörber Sebastian, Bauer Jens, Rieth Jonas, Walz Juliane S
Pembrolizumab-Associated CD8 Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma
Baldauf M, Jörger M, Flatz L, Rodriguez R, Frank S, Felbecker A, Hundsberger T. Pembrolizumab-Associated CD8 Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma. Neurol Neuroimmunol Neuroinflamm 2021; 8
06.04.2021Pembrolizumab-Associated CD8 Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma
06.04.2021Neurol Neuroimmunol Neuroinflamm 2021; 8
Baldauf Michaela, Jörger Markus, Flatz Lukas, Rodriguez Regulo, Frank Stephan, Felbecker Ansgar, Hundsberger Thomas
European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis
Loman L, Rustemeyer T, Sadowska-Przytocka A, Sánchez-Pérez J, Scherer Hofmeier K, Schliemann S, Simon D, Spiewak R, Spring P, Valiukevičienė S, Wagner N, Weisshaar E, Pesonen M, Schuttelaar M, Mahler V, Kręcisz B, Kränke B, Uter W, Armario-Hita J, Ayala F, Balato A, Ballmer-Weber B, Bauer A, Bircher A, Buhl T, Czarnecka-Operacz M, Dickel H, Fuchs T, Giménez Arnau A, John S, ESSCA Working Group. European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis. Contact dermatitis 2021
17.03.2021European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis
17.03.2021Contact dermatitis 2021
Loman Laura, Rustemeyer Thomas, Sadowska-Przytocka Anna, Sánchez-Pérez Javier, Scherer Hofmeier Kathrin, Schliemann Sibylle, Simon Dagmar, Spiewak Radoslaw, Spring Philip, Valiukevičienė Skaidra, Wagner Nicola, Weisshaar Elke, Pesonen Maria, Schuttelaar Marie L A, Mahler Vera, Kręcisz Beata, Kränke Birger, Uter Wolfgang, Armario-Hita José C, Ayala Fabio, Balato Anna, Ballmer-Weber Barbara, Bauer Andrea, Bircher Andreas J, Buhl Timo, Czarnecka-Operacz Magdalena, Dickel Heinrich, Fuchs Thomas, Giménez Arnau Ana, John Swen M, ESSCA Working Group
Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors
Gassenmaier M, Lenders M, Forschner A, Leiter U, Weide B, Garbe C, Eigentler T, Wagner N. Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors. Target Oncol 2021; 16:197-205.
08.02.2021Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors
08.02.2021Target Oncol 2021; 16:197-205
Gassenmaier Maximilian, Lenders Max M, Forschner Andrea, Leiter Ulrike, Weide Benjamin, Garbe Claus, Eigentler Thomas K, Wagner Nikolaus
Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge
Królik M, Csepregi L, Hartmann F, Engetschwiler C, Flatz L. Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge. Vaccine 2021; 39:1257-1264.
29.01.2021Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge
29.01.2021Vaccine 2021; 39:1257-1264
Królik Michał Wojciech, Csepregi Lucia, Hartmann Fabienne, Engetschwiler Céline, Flatz Lukas
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway
Maul J, Dippel M, Yawalkar N, Trüeb R, Schlapbach C, Mainetti C, Lapointe A, Laffitte E, Kolios A, Jalili A, Häusermann P, Cozzio A, Conrad C, Anzengruber F, Navarini A. Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway. Dermatology 2021; 237:166-178.
06.01.2021Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway
06.01.2021Dermatology 2021; 237:166-178
Maul Julia-Tatjana, Dippel Michaela, Yawalkar Nikhil, Trüeb Ralph, Schlapbach Christoph, Mainetti Carlo, Lapointe Anne-Karine, Laffitte Emmanuel, Kolios Antonios G A, Jalili Ahmad, Häusermann Peter, Cozzio Antonio, Conrad Curdin, Anzengruber Florian, Navarini Alexander A
Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus
Pirker I, Saulite I, von Kempis J. Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus. ACR Open Rheumatol 2021; 3:41.
03.01.2021Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus
03.01.2021ACR Open Rheumatol 2021; 3:41
Pirker Ian, Saulite Ieva, von Kempis Johannes
Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
Hasan Ali O, Penninger J, Bergthaler A, Popa A, Gómez-Mejia A, Schüpbach R, Bühler P, Vernazza P, Kahlert C, Kohler P, Albrich W, Kern L, Thiel S, Weber M, Paprotny M, Brugger S, Risch L, Bomze D, Flatz L. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:e2869-e2874.
02.01.2021Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies
02.01.2021Clin Infect Dis 2021; 73:e2869-e2874
Hasan Ali Omar, Penninger Josef M, Bergthaler Andreas, Popa Alexandra M, Gómez-Mejia Alejandro, Schüpbach Reto A, Bühler Philipp K, Vernazza Pietro, Kahlert Christian, Kohler Philipp, Albrich Werner, Kern Lukas, Thiel Sarah, Weber Myriam, Paprotny Matthias, Brugger Silvio D, Risch Lorenz, Bomze David, Flatz Lukas
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
Wagner N, Schraag A, Klumpp B, Hoetzenecker W, Berking C, Richtig E, Ziemer M, Mangana J, Terheyden P, Loquai C, Nguyen V, Gebhardt C, Meier F, Diem S, Cozzio A, Flatz L, Röcken M, Garbe C, Gassenmaier M, Weide B, Leiter U, Lenders M, Kühl K, Reinhardt L, André F, Dudda M, Ring N, Ebel C, Stäger R, Zellweger C, Lang R, Paar M, Gussek P, Richtig G, Stürmer S, Kimeswenger S, Oellinger A, Forschner A, Eigentler T. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study. J Immunother Cancer 2021; 9
01.01.2021Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study
01.01.2021J Immunother Cancer 2021; 9
Wagner Nikolaus, Schraag Amadeus, Klumpp Bernhard, Hoetzenecker Wolfram, Berking Carola, Richtig Erika, Ziemer Mirjana, Mangana Johanna, Terheyden Patrick, Loquai Carmen, Nguyen Van Anh, Gebhardt Christoffer, Meier Friedegund, Diem Stefan, Cozzio Antonio, Flatz Lukas, Röcken Martin, Garbe Claus, Gassenmaier Maximilian, Weide Benjamin, Leiter Ulrike, Lenders Max M, Kühl Kathrin, Reinhardt Lydia, André Fiona, Dudda Milena, Ring Natalie, Ebel Chiara, Stäger Ramon, Zellweger Caroline, Lang Roland, Paar Michael, Gussek Philipp, Richtig Georg, Stürmer Suzan H, Kimeswenger Susanne, Oellinger Angela, Forschner Andrea, Eigentler Thomas K
First-line treatment of NRAS-mutated metastatic melanoma with a MEK inhibitor
Bickel A, Diem S, Flatz L, Stinn B, Siano M. First-line treatment of NRAS-mutated metastatic melanoma with a MEK inhibitor. J Cancer Res Ther 2021; 17:276-278.
01.01.2021First-line treatment of NRAS-mutated metastatic melanoma with a MEK inhibitor
01.01.2021J Cancer Res Ther 2021; 17:276-278
Bickel Angelika, Diem Stefan, Flatz Lukas, Stinn Björn, Siano Marco
Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy
Bochem J, Meier F, Terheyden P, Königsrainer A, Garbe C, Flatz L, Pawelec G, Eigentler T, Löffler M, Weide B, Niessner H, Sinnberg T, Zelba H, Spreuer J, Amaral T, Gaissler A, Pop O, Thiel K, Yurttas C, Soffel D, Forchhammer S, Wistuba-Hamprecht K. Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy. J Immunother Cancer 2021; 9
01.01.2021Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy
01.01.2021J Immunother Cancer 2021; 9
Bochem Jonas, Meier Friedegund, Terheyden Patrick, Königsrainer Alfred, Garbe Claus, Flatz Lukas, Pawelec Graham, Eigentler Thomas K, Löffler Markus W, Weide Benjamin, Niessner Heike, Sinnberg Tobias, Zelba Henning, Spreuer Janine, Amaral Teresa, Gaissler Andrea, Pop Oltin, Thiel Karolin, Yurttas Can, Soffel Daniel, Forchhammer Stephan, Wistuba-Hamprecht Kilian
Healthcare provision for insect venom allergy patients during the COVID-19 pandemic
Worm M, Sturm G, Wedi B, Treudler R, Trautmann A, Schäkel K, Saloga J, Pickert J, Novak N, Jakob T, Homey B, Hötzenecker W, Hawranek T, Hartmann K, Gschwend A, Cuevas M, Brehler R, Ballmer-Weber B, Rueff F. Healthcare provision for insect venom allergy patients during the COVID-19 pandemic. Allergo J Int 2020:1-5.
08.12.2020Healthcare provision for insect venom allergy patients during the COVID-19 pandemic
08.12.2020Allergo J Int 2020:1-5
Worm Margitta, Sturm Gunter, Wedi Bettina, Treudler Regina, Trautmann Axel, Schäkel Knut, Saloga Joachim, Pickert Julia, Novak Natalija, Jakob Thilo, Homey Bernhard, Hötzenecker Wolfram, Hawranek Thomas, Hartmann Karin, Gschwend Anna, Cuevas Mandy, Brehler Randolf, Ballmer-Weber Barbara, Rueff Franziska
Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study)
Stenz N, Hofbauer G, Nägeli M, Mühlstädt M, Laffitte E, Hunger R, Harms M, Gaide O, Dickenmann M, Cozzio A, Arnold A, Stampf S, and The Swiss Transplant Cohort Study. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study). Dermatology 2020:1-11.
23.11.2020Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study)
23.11.2020Dermatology 2020:1-11
Stenz Nadja Angela, Hofbauer Günther F L, Nägeli Mirjam, Mühlstädt Michael, Laffitte Emmanuel, Hunger Robert E, Harms Mirjam, Gaide Olivier, Dickenmann Michael, Cozzio Antonio, Arnold Andreas W, Stampf Susanne, and The Swiss Transplant Cohort Study
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors
Winter J, Eigentler T, Garbe C, Röcken M, Cozzio A, Flatz L, Purde M, Weide B, Leiter U, Forschner A, Gassenmaier M, Lenders M, Wagner N. Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors. Cancer Immunol Immunother 2020; 70:1089-1099.
28.10.2020Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors
28.10.2020Cancer Immunol Immunother 2020; 70:1089-1099
Winter Johanna, Eigentler Thomas K, Garbe Claus, Röcken Martin, Cozzio Antonio, Flatz Lukas, Purde Mette-Triin, Weide Benjamin, Leiter Ulrike, Forschner Andrea, Gassenmaier Maximilian, Lenders Max M, Wagner Nikolaus
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8 T Cells
Bald T, Scolyer R, Long G, Wilmott J, Hughes B, Ahern E, Taheri T, Kristiansen G, Geyer M, Hölzel M, Seo E, Batstone M, Landsberg J, Smyth M, Martinet L, Johnston R, Möller A, Nicholson S, Veillette A, Dougall W, Flatz L, Pop O, Dietrich D, Nakamura K, Casey M, Koufariotis L, Li R, Li K, Meza Guzman L, Lima L, Das I, Krumeich S, Stannard K, Corvino D, Sundarrajan A, Aguilera A, Salim N, Jorge M, Quine B, Effern M, Jacquelin S, Madore J, Pearson S, Raghavendra A, Lepletier A, Vari F, Kelly G, Ham S, Braun M. CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8 T Cells. Immunity 2020; 53:805-823.e15.
13.10.2020CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8 T Cells
13.10.2020Immunity 2020; 53:805-823.e15
Bald Tobias, Scolyer Richard A, Long Georgina V, Wilmott James S, Hughes Brett G M, Ahern Elizabeth, Taheri Touraj, Kristiansen Glen, Geyer Matthias, Hölzel Michael, Seo Eun Y, Batstone Martin D, Landsberg Jennifer, Smyth Mark J, Martinet Ludovic, Johnston Robert J, Möller Andreas, Nicholson Sandra E, Veillette André, Dougall William C, Flatz Lukas, Pop Oltin, Dietrich Dimo, Nakamura Kyohei, Casey Mika, Koufariotis Lambros T, Li Rui, Li Kunlun, Meza Guzman Lizeth G, Lima Luize G, Das Indrajit, Krumeich Sophie, Stannard Kimberley, Corvino Dillon, Sundarrajan Ashmitha, Aguilera Amelia Roman, Salim Nazhifah, Jorge Maria Villancanas, Quine Brodie, Effern Maike, Jacquelin Sebastien, Madore Jason, Pearson Sally, Raghavendra Ashwini, Lepletier Ailin, Vari Frank, Kelly Gabrielle, Ham Sunyoung, Braun Matthias
Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8 T Cell Responses
Ring S, Królik M, Hartmann F, Schmidt E, Ali O, Ludewig B, Kochanek S, Flatz L. Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8 T Cell Responses. Mol Ther Oncolytics 2020; 19:179-187.
10.10.2020Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8 T Cell Responses
10.10.2020Mol Ther Oncolytics 2020; 19:179-187
Ring Sandra, Królik Michał Wojciech, Hartmann Fabienne, Schmidt Erika, Ali Omar Hasan, Ludewig Burkhard, Kochanek Stefan, Flatz Lukas
Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint Inhibitors
Bomze D, Asher N, Hasan A, Flatz L, Azoulay D, Markel G, Meirson T. Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint Inhibitors. JAMA Netw Open 2020; 3:e2017675.
01.10.2020Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint Inhibitors
01.10.2020JAMA Netw Open 2020; 3:e2017675
Bomze David, Asher Nethanel, Hasan Ali, Flatz Lukas, Azoulay Daniel, Markel Gal, Meirson Tomer
Walnut Allergy Across Europe: Distribution of Allergen Sensitization Patterns and Prediction of Severity
Lyons S, Pontoppidan B, Popov T, Prado N, Purohit A, Reig I, Seneviratne S, Sinaniotis A, Vassilopoulou E, Versteeg S, Vieths S, Zwinderman A, Welsing P, Mills E, Ballmer-Weber B, Knulst A, Fernández-Rivas M, Papadopoulos N, Lidholm J, Datema M, Le T, Asero R, Barreales L, Belohlavkova S, de Blay F, Clausen M, Dubakiene R, Fernández-Perez C, Fritsche P, Gislason D, Hoffmann-Sommergruber K, Jedrzejczak-Czechowicz M, Jongejan L, Kowalski M, Kralimarkova T, Van Ree R. Walnut Allergy Across Europe: Distribution of Allergen Sensitization Patterns and Prediction of Severity. J Allergy Clin Immunol Pract 2020
08.09.2020Walnut Allergy Across Europe: Distribution of Allergen Sensitization Patterns and Prediction of Severity
08.09.2020J Allergy Clin Immunol Pract 2020
Lyons Sarah A, Pontoppidan Bo, Popov Todor A, Prado Nayade Del, Purohit Ashok, Reig Isabel, Seneviratne Suranjith L, Sinaniotis Athanasios, Vassilopoulou Emilia, Versteeg Serge A, Vieths Stefan, Zwinderman Aeilko H, Welsing Paco M J, Mills E N Clare, Ballmer-Weber Barbara, Knulst André C, Fernández-Rivas Montserrat, Papadopoulos Nikolaos G, Lidholm Jonas, Datema Mareen R, Le Thuy-My, Asero Riccardo, Barreales Laura, Belohlavkova Simona, de Blay Frédéric, Clausen Michael, Dubakiene Ruta, Fernández-Perez Cristina, Fritsche Philipp, Gislason David, Hoffmann-Sommergruber Karin, Jedrzejczak-Czechowicz Monika, Jongejan Laurian, Kowalski Marek L, Kralimarkova Tanya Z, Van Ree Ronald
Predicting food allergy: The value of patient history reinforced
Lyons S, Mustakov T, van Os-Medendorp H, Papadopoulos N, Popov T, Potts J, Versteeg S, Xepapadaki P, Welsing P, Mills C, Van Ree R, Kralimarkova T, Kummeling I, Kowalski M, Knulst A, Burney P, Fernández-Rivas M, Ballmer-Weber B, Barreales L, Bieli C, Clausen M, Dubakiene R, Fernández-Perez C, Jedrzejczak-Czechowicz M, Le T. Predicting food allergy: The value of patient history reinforced. Allergy 2020
07.09.2020Predicting food allergy: The value of patient history reinforced
07.09.2020Allergy 2020
Lyons Sarah A, Mustakov Tihomir B, van Os-Medendorp Harmieke, Papadopoulos Nikolaos G, Popov Todor A, Potts James, Versteeg Serge A, Xepapadaki Paraskevi, Welsing Paco M J, Mills Clare, Van Ree Ronald, Kralimarkova Tanya, Kummeling Ischa, Kowalski Marek L, Knulst André C, Burney Peter G J, Fernández-Rivas Montserrat, Ballmer-Weber Barbara, Barreales Laura, Bieli Christian, Clausen Michael, Dubakiene Ruta, Fernández-Perez Cristina, Jedrzejczak-Czechowicz Monika, Le Thuy-My
Formaldehyde 2% is not a useful means of detecting allergy to formaldehyde releasers- results of the ESSCA network, 2015-2018
Whitehouse H, Johnston G, Filon F, Mahler V, Pesonen M, Rustemeyer T, Schuttelaar M, Valiukevičienė S, Weisshaar E, Werfel T, Giménez-Arnau A, Gallo R, Uter W, Geier J, Ballmer-Weber B, Bauer A, Cooper S, Czarnecka-Operacz M, Simon D, Dickel H, Fortina A, Wilkinson S. Formaldehyde 2% is not a useful means of detecting allergy to formaldehyde releasers- results of the ESSCA network, 2015-2018. Contact dermatitis 2020
02.09.2020Formaldehyde 2% is not a useful means of detecting allergy to formaldehyde releasers- results of the ESSCA network, 2015-2018
02.09.2020Contact dermatitis 2020
Whitehouse Heather, Johnston Graham A, Filon Francesca Laresse, Mahler Vera, Pesonen Maria, Rustemeyer Thomas, Schuttelaar Marie L A, Valiukevičienė Skaidra, Weisshaar Elke, Werfel Thomas, Giménez-Arnau Ana Maria, Gallo Rosella, Uter Wolfgang, Geier Johannes, Ballmer-Weber Barbara, Bauer Andrea, Cooper Susan, Czarnecka-Operacz Magdalena, Simon Dagmar, Dickel Heinrich, Fortina Anna Belloni, Wilkinson Stephen Mark